These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7494223)

  • 21. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
    Fisher B; Redmond C; Legault-Poisson S; Dimitrov NV; Brown AM; Wickerham DL; Wolmark N; Margolese RG; Bowman D; Glass AG
    J Clin Oncol; 1990 Jun; 8(6):1005-18. PubMed ID: 2189950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen therapy for patients with breast cancer.
    Huiart L; Ferdynus C; Giorgi R
    Lancet; 2013 Jun; 381(9883):2077. PubMed ID: 23769224
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of adjuvant tamoxifen: the latest results from the Cancer Research Campaign Adjuvant Breast Trial. Cancer Research Campaign Breast Cancer Trials Group.
    Eur J Cancer; 1992; 28A(4-5):904-7. PubMed ID: 1524921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Gal D; Weiselberg L; Runowicz CD
    J Natl Cancer Inst; 1994 Aug; 86(16):1252-3; author reply 1255. PubMed ID: 8040896
    [No Abstract]   [Full Text] [Related]  

  • 25. Tamoxifen therapy for patients with breast cancer.
    Neven P; Joensuu H; Osborne K; Cardoso F; Loibl S; Linn S; Goldhirsch A; Ortmann O; Senn HJ; Hayes DF
    Lancet; 2013 Jun; 381(9883):2078. PubMed ID: 23769226
    [No Abstract]   [Full Text] [Related]  

  • 26. Trial of tamoxifen at a dose of 40 mg daily after disease progression during tamoxifen therapy at a dose of 20 mg daily.
    Stewart JF; Minton MJ; Rubens RD
    Cancer Treat Rep; 1982 Jun; 66(6):1445-6. PubMed ID: 7044536
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of two and three years of adjuvant tamoxifen.
    Wolmark N; Redmond C; Fisher B
    Horm Res; 1989; 32 Suppl 1():166-8. PubMed ID: 2613201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group.
    J Natl Cancer Inst; 1996 Dec; 88(24):1834-9. PubMed ID: 8961973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Carcangiu ML
    J Natl Cancer Inst; 1994 Aug; 86(16):1251-2; author reply 1253-5. PubMed ID: 8040895
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adjuvant tamoxifen duration: more large-scale randomized evidence is needed].
    Davies C; Nomura Y; Ohashi Y
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1203-9. PubMed ID: 9279337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer and duration of tamoxifen.
    Prescrire Int; 2015 Sep; 24(163):220. PubMed ID: 26417636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Love RR
    J Natl Cancer Inst; 1994 Jul; 86(13):1025-6. PubMed ID: 8007012
    [No Abstract]   [Full Text] [Related]  

  • 33. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.
    ; Buzdar A; Howell A; Cuzick J; Wale C; Distler W; Hoctin-Boes G; Houghton J; Locker GY; Nabholtz JM
    Lancet Oncol; 2006 Aug; 7(8):633-43. PubMed ID: 16887480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
    Fisher B; Dignam J; Wolmark N; DeCillis A; Emir B; Wickerham DL; Bryant J; Dimitrov NV; Abramson N; Atkins JN; Shibata H; Deschenes L; Margolese RG
    J Natl Cancer Inst; 1997 Nov; 89(22):1673-82. PubMed ID: 9390536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
    Thomson CA; Chow HHS; Wertheim BC; Roe DJ; Stopeck A; Maskarinec G; Altbach M; Chalasani P; Huang C; Strom MB; Galons JP; Thompson PA
    Breast Cancer Res Treat; 2017 Aug; 165(1):97-107. PubMed ID: 28560655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.
    Rocchi A; Verma S
    Support Care Cancer; 2006 Sep; 14(9):917-27. PubMed ID: 16596419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of stroke with tamoxifen in NSABP B-24.
    Dignam JJ; Fisher B
    Lancet; 2000 Mar; 355(9206):848-9. PubMed ID: 10711957
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.
    Lyman GH; Cosler LE; Kuderer NM; Hornberger J
    Cancer; 2007 Mar; 109(6):1011-8. PubMed ID: 17311307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five years of tamoxifen--or more?
    Peto R
    J Natl Cancer Inst; 1996 Dec; 88(24):1791-3. PubMed ID: 8961965
    [No Abstract]   [Full Text] [Related]  

  • 40. Ocular assessment of patients treated with tamoxifen.
    Beck M; Mills PV
    Cancer Treat Rep; 1979; 63(11-12):1833-4. PubMed ID: 526917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.